New diabetes tech is coming. But will it make much difference?
(By Rebecca Robbins for STAT) Pharma and tech giants are pouring hundreds of millions into diabetes technology, designing gadgets and
Read More(By Rebecca Robbins for STAT) Pharma and tech giants are pouring hundreds of millions into diabetes technology, designing gadgets and
Read More(By Alison Kodjak for NPR) Three doctors who have led a task force that evaluates preventive medical services say the
Read More(By Debra Patt for STAT) Given its name, you’d expect the federal 340B Drug Discount Program1 to save money for
Read More(By Ed Silverman for STAT) Someone at Nippon Fine Chemical must have been very nervous when an investigator from the
Read More(By Rhitu Chatterjee for NPR) Diet and nutrition are now the biggest risk factors for people’s health across the globe,
Read More(By Virginia Anderson for NPR) Shela Bryan, 63, has been comparing prices for individual health insurance plans since May, and
Read More(By Melissa Quinn for The Daily Signal) Republican Rep. Chris Stewart of Utah has mounted a campaign urging House Speaker
Read More(By Ed Silverman for STAT) At a time when drug makers are under intense scrutiny for their pricing, Ariad Pharmaceuticals
Read More(‘By Ed Silverman for STAT) Mylan reached a $465 million settlement on Friday with the US Department of Justice and
Read More(By Meghana Keshavan for STAT) The race to create the next potent ovarian cancer drug is coming to a head. Ovarian
Read More